BUSINESS● LOWJun 29 · Jun 29, 2026, 9:10 AM
Ipsen to buy Kartos Therapeutics for $450M to boost oncology pipeline
Seeking Alpha Tech
Ipsen plans to acquire Kartos Therapeutics for $450 million, aiming to enhance its oncology drug development pipeline.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS18m agoNvidia continues impressive path at GTC Berlin, BNP Paribas saysSeeking Alpha TechBUSINESS22m agoU.S. natural gas inventory net change of +77 Bcf for week ended October 16 – EIASeeking Alpha Tech